stockrow
Friday 6 November 2026
Export INNV’s income statement to Excel — free account
InnovAge Holding Corp.
INNV Healthcare Medical Care Facilities
InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025.
- Revenue
- +12.1%
- EPS
- +155.0%
- Free cash flow
- +622.8%
- Total debt
- −16.7%
Quarter to September 2026, against a year earlier
9.04
0.75
−7.66%
Follow INNV
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
103.80 | 0.00 | 0.00 | 120.55 |
P/S ratio |
0.77 | 1.15 | 1.62 | 1.18 | |
P/FCF ratio |
15.20 | 25.40 | 31.73 | 16.47 | |
P/Operating CF |
32.97 | 60.00 | 75.53 | 41.77 | |
P/B ratio |
2.70 | 4.68 | 6.73 | 4.65 | |
Price to Tangible BV |
6.09 | 12.46 | 17.20 | 10.64 | |
EV/Sales |
0.70 | 1.07 | 1.54 | 1.07 | |
EV/EBITDA |
22.45 | 110.85 | 62.08 | 29.57 | |
EV/Operating CF |
10.90 | 19.33 | 23.53 | 12.20 | |
EV/FCF |
13.86 | 23.65 | 30.05 | 14.98 | |
Quick Ratio |
1.04 | 0.87 | 0.92 | 0.98 | |
Current Ratio |
1.26 | 1.03 | 1.05 | 1.16 | |
Net Debt/EBITDA |
(3.38) | 3.12 | (5.08) | (4.17) | |
Debt/Assets |
12.12% | 11.59% | 10.10% | 9.69% | |
Debt/Equity |
0.24 | 0.27 | 0.24 | 0.21 | |
Asset Turnover |
1.74 | 1.75 | 1.83 | 1.90 | |
Operating CF/Net income |
2.01 | (0.62) | 2.57 | 1.47 | |
Capex/Depreciation |
(1.20) | 0.02 | (0.65) | (0.51) | |
Interest Coverage |
10.64 | (29.43) | 13.13 | 163.82 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
14.47% | 33.85% | 16.42% | 14.27% | |
Intangible Assets out of Total Assets |
0.28 | 0.27 | 0.26 | 0.26 | |
Share Based Compensation of Revenue |
0.51% | 0.71% | 0.66% | 0.66% | |
Graham Net Nets |
(0.12) | (0.10) | (0.06) | (0.07) | |
Graham Number |
1.47 | 0.00 | 0.00 | 1.76 | |
Earnings Yield |
0.96% | (1.12%) | (0.17%) | 0.83% | |
Free Cash Flow Yield |
6.58% | 3.94% | 3.15% | 6.07% | |
Revenue per Share |
1.77 | 1.86 | 1.93 | 1.94 | |
Operating CF per Share |
0.16 | 0.13 | 0.16 | 0.21 | |
Capex per Share |
(0.04) | 0.00 | (0.03) | (0.02) | |
Free Cash Flow per Share |
0.11 | 0.13 | 0.13 | 0.19 | |
Cash per Share |
0.93 | 1.02 | 1.04 | 1.19 | |
Shareholders Equity per Share |
1.92 | 1.72 | 1.76 | 1.89 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.92 | 1.72 | 1.76 | 1.89 | |
Free Cash Flow |
15.28 | 18.25 | 17.02 | 25.75 | |
Working Capital |
37.15 | 6.73 | 10.42 | 31.31 | |
Capital Expenditures |
(6.08) | 0.11 | (4.27) | (2.99) | |
Net Current Asset Value |
(84.46) | (112.00) | (104.32) | (81.23) | |
EV/EBIT |
69.48 | 0.00 | 581.74 | 75.42 | |
Capex to Sales |
0.03 | 0.00 | 0.02 | 0.01 | |
Price to Operating Income |
76.20 | 0.00 | 614.22 | 82.91 | |
| Other line items | |||||
Average Receivables |
38.85 | 39.85 | 42.67 | 26.41 | |
Average Payables |
56.97 | 90.38 | 96.05 | 75.74 | |
Average Assets |
526.13 | 542.02 | 542.12 | 536.60 | |
Average Common Equity |
258.76 | 239.19 | 238.33 | 253.89 |
Columns are period end dates · fundamentals updated 5 Nov 2026